Organ Variation in the Mutagenicity of Dimethylnitrosamine in Big Blue® Mice

Environmental and Molecular Mutagenesis

Volumn 28, Issue 4, 1996, Pages 348-353

  Suzuki, T ^a   Itoh, T ^a   Hayashi, M ^a   Nishikawa, Y ^a   Ikezaki, S ^a   Furukawa, F ^a   Takahashi, M ^a   Sofuni, T ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Cell proliferation; Dimethylnitrosamine; lacl; Micronucleus; Organ specificity; Transgenic animals

Indexed keywords

ANIMALIA;

BACTERIAL PROTEIN; CARCINOGEN; CYCLINE; DIMETHYLNITROSAMINE; ESCHERICHIA COLI PROTEIN; LACI PROTEIN, BACTERIA; MUTAGENIC AGENT; REPRESSOR PROTEIN;

ANIMAL; ARTICLE; BLOOD; C57BL MOUSE; CARCINOGEN TESTING; CELL DIVISION; DRUG EFFECT; GENETICS; IMMUNOLOGY; MALE; METABOLISM; METHODOLOGY; MICRONUCLEUS TEST; MOUSE; MUTAGEN TESTING; MUTATION; TISSUE DISTRIBUTION; TRANSGENIC MOUSE;

ANIMALS; BACTERIAL PROTEINS; BLOOD; CARCINOGENICITY TESTS; CARCINOGENS; CELL DIVISION; DIMETHYLNITROSAMINE; ESCHERICHIA COLI PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICRONUCLEUS TESTS; MUTAGENICITY TESTS; MUTAGENS; MUTATION; PROLIFERATING CELL NUCLEAR ANTIGEN; REPRESSOR PROTEINS; TISSUE DISTRIBUTION;

EID: 0030330424     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-2280(1996)28:4<348::aid-em8>3.0.co;2-7     Document Type: Article

References (24)

1. 32P bladder DNA adduction. Carcinogenesis 15:2291-2296.
2. Butterworth BE, Popp JA, Conolly RB, Goldsworthy TL (1992): Chemically induced cell proliferation in carcinogenesis. In Vainio H, Magee P, McGregor D, McMichael AJ (eds.): "Mechanisms of Carcinogenesis in Risk Identification." IARC, Lyon, IARC Scientific Publ. No. 116, pp 279-305.
3. CSGMT (Collaborative Study Group for the Micronucleus Tests) (1993): Evaluation of mouse micronucleus assay to screen carcinogens. MMS Commun Suppl 1:1-32.
4. Den Engelse L, Bentvelzen PAJ, Emmelot P (1969/1970): Studies on lung tumors. I. Methylation of deoxyribonucleic acid and tumor formation following administration of dimethylnitrosamine to mice. Chem Biol Interact 1:394-406.
5. Frei JV (1970): Toxicity, tissue changes, and tumor induction in inbred Swiss mice by methylnitrosamine and -amide compounds. Cancer Res 30:11-17.
6. Gorelick NJ (1995): Overview of mutation assays in transgenic mice for routine testing. Environ Mol Mutagen 25:218-230.
7. Gossen JA, DeLeeuw WJ, Tan CH, Zwarthoff EC, Berends F, Lohman PHM, Knook DL, Vijg J (1989): Efficient rescue of integrated shuttle vectors from transgenic mice: A model for studying mutations in vivo. Proc Natl Acad Sci USA 86:7971-7975.
8. Hayashi M, Morita T, Kodama Y, Sofuni T, Ishidate M Jr (1990): The micronucleus assay with mouse peripheral blood reticulocytes using acridine orange-coated slides. Mutat Res 245:245-249.
9. Ii Y, Cardesa A, Patil K, Althoff J, Pour P (1976): Comparative studies of neoplastic response to a single dose of nitroso compounds. Z Krebsforsch 86:165-170.
10. IARC (International Agency for Research on Cancer) (1978): "IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Some N-Nitroso Compounds," Vol. 17. Lyon, France: International Agency for Research on Cancer, pp 125-175.
11. Kohler SW, Provost GS, Fieck A, Kretz PL, Bullock WO, Sorge JA, Putman DL, Short JM (1991): Spectra of spontaneous and mutagen-induced mutations in the lacl gene in transgenic mice. Proc Natl Acad Sci USA 88:7958-7962.
12. Mirsalis JC, Provost GS, Matthews CD, Hamner RT, Schindler JE, O'Loughlin KG, MacGregor JT, Short JM (1993): Induction of hepatic mutations in lacl transgenic mice. Mutagenesis 8:265-271.
13. Mirsalis JC, Monforte JA, Winegar RA (1995): Transgenic animal models for detection of in vivo mutations. Annu Rev Pharmacol Toxicol 35:145-164.
14. Morrison V, Ashby J (1994a): A preliminary evaluation of the performance of the Muta Mouse (lacZ) and Big Blue (lacl) transgenic mouse mutation assays. Mutagenesis 9:367-375.
15. Morrison V, Ashby J (1994b): Reconciliation of five negative and four positive reports of the activity of dimethylnitrosamine in the mouse bone marrow micronucleus assay. Mutagenesis 9:361-365.
16. Nishikawa A, Furukawa F, Imazawa T, Ikezaki S, Otoshi T, Fukushima S, Takahashi M (1995): Cell proliferation in lung fibrosis-associated hyperplastic lesions. Hum Exp Toxicol 14:701-705.
17. Noronha RFX (1975): The inhibition of dimethylnitrosamine-induced renal tumorigenesis in NZO/B1 mice by orchiectomy. Invest Urol 13:136-141.
18. Rabbitts TH (1994): Chromosomal translocations in human cancer. Nature 372:143-149.
19. Rogers BJ, Provost GS, Young RR, Putman DL, Short JM (1995): Intralaboratory optimization and standardization of mutant screening conditions used for a lambda/lacl transgenic mouse mutagenesis assay (I). Mutat Res 327:57-66.
20. Stanley LA (1995) Molecular aspects of chemical carcinogenesis: the roles of oncogenes and tumour suppressor genes. Toxicology 96:173-194.
21. Suzuki T, Hayashi M, Sofuni T, Myhr BC (1993) The concomitant detection of gene mutation and micronuclei induction by mitomycin C in vivo using lacZ transgenic mice. Mutat Res 285:219-224.
22. Suzuki T, Hayashi M, Sofuni T (1994) Initial experiences and future directions for transgenic mouse mutation assays. Mutat Res 307:489-494.
23. Suzuki T, Hayashi M, Ochiai M, Wakabayashi K, Ushijima T, Sugimura T, Nagao M, Sofuni T (1996): Organ variation in the mutagenicity of MeIQ in Big Blue® lacl transgenic mice. Mutat Res 369:45-49.
24. Tinwell H, Lefevre PA, Ashby J (1994) Mutation studies with dimethyl nitrosamine in young and old lacl transgenic mice. Mutat Res 307:501-508.